Skip Navigation

Next billion dollar drug?

Next billion dollar drug?

Billion dollar opportunity for BioMarin? CNBC's Meg Terrell takes a look at the company's focus on achondroplasia.

03:25

Thu, May 28 20155:40 PM EDT

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Google's fate hinges on this man: Demis Hassabis

Google's fate hinges on this man: Demis Hassabis

Austin Ekeler on joining the Washington Commanders

Austin Ekeler on joining the Washington Commanders

The Fed on rate cut timeline, restrictive monetary policy and inflation target

The Fed on rate cut timeline, restrictive monetary policy and inflation target

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Google's fate hinges on this man: Demis Hassabis

Google's fate hinges on this man: Demis Hassabis

Austin Ekeler on joining the Washington Commanders

Austin Ekeler on joining the Washington Commanders

The Fed on rate cut timeline, restrictive monetary policy and inflation target

The Fed on rate cut timeline, restrictive monetary policy and inflation target